Literature DB >> 7656915

Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism.

D H Biesma1, A Van de Wiel, Y Beguin, R J Kraaijenhagen, J J Marx.   

Abstract

The decrease in haemoglobin concentration commonly observed after major surgery is usually corrected by red cell transfusions or oral iron medication. The increased awareness of blood-transmissible diseases has led to the restrictive use of homologous blood and to interest in alternatives for correcting anaemia. We investigated the pathophysiology of postoperative anaemia by studying variables of erythropoiesis, iron metabolism, and inflammation in 48 consecutive patients who underwent total hip replacement. Haemoglobin concentration remained low during 14 days after surgery with only a mild increase in erythropoietin concentration and reticulocyte count. No increase in serum transferrin receptor concentration was observed during the first 2 weeks after surgery. Postoperative serum ferritin increased, whereas serum iron, transferrin and transferrin saturation decreased significantly. There was a marked increase in interleukin-6 and C-reactive protein with maximal values on the 1st and 4th post-operative day, respectively. At 6 weeks after surgery, haemoglobin concentration and variables of iron metabolism were almost at the preoperative level and serum transferrin receptor concentration was significantly increased, indicating increased erythropoietic activity. These changes were preceded by the normalization of interleukin-6 and C-reactive protein levels. Haemoglobin, iron, transferrin, and ferritin concentrations were not influenced by iron therapy during the postoperative period and no differences of erythropoietic and iron variables were observed between transfused and non-transfused patients. In conclusion, post-operative erythropoiesis is associated with an inflammatory effect of surgery on iron metabolism, which can explain, despite a slightly increased production of erythropoietin, the persistence of anaemia and the lack of effect of iron supplementation after surgery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7656915     DOI: 10.1111/j.1365-2362.1995.tb01718.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

2.  Hematological variables and iron status in abdominoplasty after bariatric surgery.

Authors:  Juan Carlos Montano-Pedroso; Elvio Bueno Garcia; Ivan Rene Viana Omonte; Mario Guilherme Cesca Rocha; Lydia Masako Ferreira
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

3.  The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial.

Authors:  Martin Rowlands; Daren P Forward; Opinder Sahota; Iain K Moppett
Journal:  Trials       Date:  2013-09-09       Impact factor: 2.279

4.  C-reactive protein, glucose and iron concentrations are significantly altered in dogs undergoing open ovariohysterectomy or ovariectomy.

Authors:  Elena Regine Moldal; Mads Jens Kjelgaard-Hansen; Marijke Elisabeth Peeters; Ane Nødtvedt; Jolle Kirpensteijn
Journal:  Acta Vet Scand       Date:  2018-05-30       Impact factor: 1.695

5.  The Effect of Intraoperative Ferric Carboxymaltose in Joint Arthroplasty Patients: A Randomized Trial.

Authors:  Hee-Sun Park; Tae-Yop Kim; Ha-Jung Kim; Young-Jin Ro; Hwa-Young Jang; Won Uk Koh
Journal:  J Clin Med       Date:  2019-10-13       Impact factor: 4.241

6.  Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial.

Authors:  Juan Carlos Montano-Pedroso; Elvio Bueno Garcia; Neil Ferreira Novo; Daniela Francescato Veiga; Lydia Masako Ferreira
Journal:  Trials       Date:  2016-04-12       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.